METHODS FOR RESTORING CORTICOSTEROID SENSITIVITY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160136272A1
SERIAL NO

14890921

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to use of therapeutic agents that specifically bind and inhibit TLR3 signalling in order to sensitize patients to treatment with corticosteroids, notably for the treatment and prevention of inflammatory and autoimmune disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INNATE PHARMAMARSEILLE FRANCE MARSEILLE BOUCHES-DU-RHONE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BUFFET, RENAUD BOULOGNE, FR 10 32
PATUREL, CARINE MARCY L'ETOILE, FR 52 237

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation